-
Initiating treatment for hypercholesterolemia at age 30 years instead of age 60 years might very well prevent not just 30% of the CAD events as occurred in the 5-year statin trials, but perhaps as many as 60% of the CAD events lifetime.
-
-
In a very large Norwegian study, use of screening mammography was associated with a reduction in the rate of death from breast cancer, but the screening itself accounted for only about a third of the total reduction in death rate.
-
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
A unique study pairing the use of a standard SSRI and SAMe against major depression in subjects who had not responded adequately to SSRI monotherapy suggests safety and significant efficacy over a 6-week trial period.
-
Results of this methodologically sound trial strongly suggest that moderate-dose B vitamin therapy has a protective effect against the rapidly progressive brain atrophy commonly seen in elderly people with mild cognitive impairment (MCI). The intervention was safe and effective over a 2-year time frame, and shows promise for slowing the inexorable progression of MCI to frank dementia.
-
Fibromyalgia patients were randomized to a treatment protocol consisting of 12 weeks of tai chi instruction and practice or a control intervention of wellness education and stretching exercises also of 12 weeks duration. The tai chi treatment group demonstrated clinically significant improvements in pain and quality of life compared to the control group and these improvements were maintained at 24-week follow up.
-
-
Low-dose aspirin, given before 17 weeks, significantly decreases the risk of preeclampsia, severe preeclampsia, IUGR, and preterm birth, compared with its effect when given after that time.
-
Recent decades have seen a dramatic expansion in the visibility of ethnic and cultural diversity in the United States.